About Secura Bio
Secura Bio is a company based in Henderson (United States) founded in 2018. Secura Bio has raised $55 million across 2 funding rounds from investors including Athyrium Capital Management. Secura Bio offers products and services including COPIKTRA. Secura Bio operates in a competitive market with competitors including OPEN Health, Target RWE, Abacus Medicine, STATinMED Research and Hylant, among others.
- Headquarter Henderson, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Secura Bio, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$55 M (USD)
in 2 rounds
-
Latest Funding Round
$55 M (USD), Series A
Mar 13, 2019
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Secura Bio
Secura Bio offers a comprehensive portfolio of products and services, including COPIKTRA.
Medication for treating certain cancers and blood disorders.
People of Secura Bio
Unlock access to complete
Funding Insights of Secura Bio
Secura Bio has successfully raised a total of $55M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $55 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Secura Bio
Secura Bio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Athyrium Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Locked | Locked | Locked |
Investor details for Secura Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Secura Bio
Investment portfolio details for Secura Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Secura Bio
Detailed financials for Secura Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Secura Bio Comparisons
Peer comparison for Secura Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Secura Bio
Secura Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OPEN Health, Target RWE, Abacus Medicine, STATinMED Research and Hylant, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of healthcare marketing services
|
|
| Locked | Locked | Locked |
Marketing services to the pharmaceutical industry are provided.
|
|
| Locked | Locked | Locked |
Consulting services for market access, health economics and outcomes research
|
|
| Locked | Locked | Locked |
Healthcare data analytics services provider
|
|
| Locked | Locked | Locked |
Offers business insurance, employee benefits, and risk consulting services worldwide.
|
Detailed competitors of Secura Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Secura Bio
Complete news archive for Secura Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Secura Bio
Secura Bio was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Secura Bio is headquartered in Henderson, United States. It is registered at Henderson, Nevada, United States.
Secura Bio is a funded company, having raised a total of $55M across 2 funding rounds to date.
Secura Bio was founded in 2018 and is based in Henderson, United States. Services in market access and health outcomes consulting are offered within the pharmaceutical sector. Focus is placed on FARYDAK, a panobinostat capsule capsule utilized for multiple myeloma treatment. Operations emphasize support for drug commercialization and outcomes research in the biotech industry.
Secura Bio's top competitors include OPEN Health, Abacus Medicine and Target RWE.
Secura Bio offers COPIKTRA.
Secura Bio has 1 investor. Key investors include Athyrium Capital Management.